Natural Alternatives International, Inc. Announces Fiscal 2014 Q2 Results PR Newswire SAN MARCOS, Calif., Feb. 12, 2014 SAN MARCOS, Calif., Feb. 12, 2014 /PRNewswire/ --Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced net income of $194,000 or $0.03 per diluted share on net sales of $16.5 million for the quarter ended December 31, 2013. Net sales for the three months ended December 31, 2013 increased by $2.8 million or 20.4% from $13.7 million recorded in the comparable prior year period. For the quarter ended December 31, 2013, contract manufacturing sales increased $2.5 million or 20.1% from the comparable quarter last year due primarily to higher sales of established products from existing costumers and new product sales from new customers. Patent and trademark licensing revenue increased 39.9% to $1.2 million during the quarter ended December 31, 2013 as compared to the prior year period. Our branded products sales totaled $278,000 for the second quarter of fiscal 2014 as compared to $338,000 for the comparable prior year period. Net sales for the six months ended December 31, 2013 increased 11.6% to $33.6 million from $30.1 million recorded in the comparable prior year period. Contract manufacturing sales during the first six months of fiscal 2014 increased $3.1 million or 11.4% from the comparable prior year period and patent and trademark licensing revenue increased $500,000 or 21.5% during this same period. Our branded products sales decreased $85,000 or 12.5% for the first six months of fiscal 2014. Net income for the first six months of fiscal 2014 totaled $282,000 or $0.04 per diluted share compared to net income of $799,000 or $0.12 per diluted share in the comparable prior year period. The decline in net income was primarily attributable to lower average sales prices for a portion of our higher volume products, an unfavorable international sales mix and lower average EUR exchange rates. Patent litigation and prosecution expenses totaled $1.3 million for the first six months of fiscal 2014 as compared to $1.4 million for the comparable prior year period. As of December 31, 2013, we had cash of $16.4 million and working capital of $29.2 million compared to $16.7 million and $29.4 million, respectively, as of June 30, 2013. As of December 31, 2013, we had $5.6 million available under our line of credit agreements with no amount outstanding. Mark A. LeDoux, Chairman and Chief Executive Officer commented, "As we exited our fiscal second quarter we realized an improvement in the sales order flow from several customers who completed their inventory reduction and product and packaging reconfiguration programs that we reported during the prior quarter. We continue to see significant growth in multiple Asian markets and continued business opportunities driven from what we believe is a growing trend to do business with companies like NAI with a positive regulatory reputation in the global markets. "New products have been launched and more are anticipated from our Swiss subsidiary in Europe, many of which take advantage of the 'approved health claims' we can help to deliver. With the Sochi Olympics under way, we are gratified to know that many of the participating Olympians have been training on our patented CarnoSyn® brand of beta-alanine. We also remain hopeful the litigation we have initiated against several infringers of our beta-alanine patents will conclude favorably in the not too distant future. We are optimistic as we enter the second half of our fiscal year that our financial performance should continue to improve." NAI, headquartered in San Marcos, California, is a leading formulator, manufacturer and marketer of nutritional supplements and provides strategic partnering services to its customers. Our comprehensive partnership approach offers a wide range of innovative nutritional products and services to our clients including: scientific research, clinical studies, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review and international product registration assistance. For more information about NAI, please see our website at http://www.nai-online.com. This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 that are not historical facts and information. These statements represent our intentions, expectations and beliefs concerning future events, including, among other things, our expectations and beliefs with respect to our future financial and operating results, including the amount of our future revenue and profits and our future financial condition, our ability to expand our contract manufacturing business and patent estate, comply with Good Manufacturing Practices and other applicable regulations and standards, improve stockholder value, remain debt free, develop, maintain or increase sales to new and existing customers, and successfully maintain and enforce our intellectual property rights, as well as future economic conditions and the impact of such conditions on our business. We wish to caution readers these statements involve risks and uncertainties that could cause actual results and outcomes for future periods to differ materially from any forward-looking statement or views expressed herein. NAI's financial performance and the forward-looking statements contained herein are further qualified by other risks including those set forth from time to time in the documents filed by us with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q. CONTACT – Kenneth Wolf, Chief Operating and Chief Financial Officer, Natural Alternatives International, Inc., at 760-736-7700 or firstname.lastname@example.org. Web site: http://www.nai-online.com NATURAL ALTERNATIVES INTERNATIONAL, INC. CONDENSED CONSOLIDATED STATEMENTS OF INCOME (In thousands, except per share data) (Unaudited) Three Months Ended Six Months Ended December 31, December 31, 2013 2012 2013 2012 NET SALES $16,475 100.0% $13,686 100.0% $33,630 100.0% $30,146 100.0% Cost of goods 13,950 84.7% 11,627 85.0% 28,371 84.4% 24,385 80.9% sold Gross profit 2,525 15.3% 2,059 15.0% 5,259 15.6% 5,761 19.1% Selling, general & 2,261 13.7% 2,332 17.0% 4,905 14.6% 5,005 16.6% administrative expenses INCOME (LOSS) FROM 264 1.6% (273) -2.0% 354 1.1% 756 2.5% OPERATIONS Other income (expense) , 1 0.0% 7 0.1% 33 0.1% (5) 0.0% net INCOME (LOSS) 265 1.6% (266) -1.9% 387 1.2% 751 2.5% BEFORE TAXES Income tax 71 (368) 105 (48) expense NET INCOME $ $ $ $ 194 102 282 799 NET INCOME PER COMMON SHARE: Basic: $0.03 $0.01 $0.04 $0.12 Diluted: $0.03 $0.01 $0.04 $0.12 WEIGHTED AVERAGE COMMON SHARES OUTSTANDING: Basic 6,817 6,891 6,817 6,904 Diluted 6,850 6,900 6,847 6,915 NATURAL ALTERNATIVES INTERNATIONAL, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands) (Unaudited) December 31, June 30, 2013 2013 ASSETS Cash and cash equivalents $16,415 $16,697 Accounts receivable, net 5,639 6,605 Inventories, net 11,777 10,035 Deferred income taxes 609 609 Other current assets 1,214 1,377 Total current assets 35,654 35,323 Property and equipment, net 9,298 9,205 Deferred income taxes 1,527 1,527 Other noncurrent assets, net 746 585 Total Assets $47,225 $46,640 LIABILITIES AND STOCKHOLDERS' EQUITY Accounts payable and accrued liabilities $6,653 $6,076 Deferred rent 75 225 Total Liabilities 6,728 6,301 Stockholders' Equity 40,497 40,339 Total Liabilities and Stockholders' Equity $47,225 $46,640 SOURCE Natural Alternatives International, Inc. Website: http://www.nai-online.com
Natural Alternatives International, Inc. Announces Fiscal 2014 Q2 Results
Press spacebar to pause and continue. Press esc to stop.